Anthem Biosciences Limited has disclosed a violation of its Code of Conduct by a designated person, as per a recent regulatory filing. The company reported that the individual in question traded in company securities during a trading window closure period, contravening the SEBI Prohibition of Insider Trading Regulations.

Details of the Violation

The company has provided the following information regarding the incident:

Company's Response

Anthem Biosciences has stated that the matter will be tabled at the forthcoming Audit Committee meeting. The company has committed to providing a detailed disclosure and information about the action taken in due course.

Regulatory Compliance

The disclosure was made in compliance with Regulation 9(1) of the SEBI PIT Regulations and the company's internal Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons.

Implications

This incident highlights the importance of adherence to insider trading regulations and company policies. It also underscores the need for designated persons within companies to be vigilant about trading window restrictions to maintain market integrity and investor confidence.

Anthem Biosciences has assured that it will provide further details and information about the actions taken in response to this violation, in accordance with SEBI Master Circular No. SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/039 dated March 23, 2023.

Investors and market participants may be watching for the outcome of the Audit Committee meeting and the subsequent actions taken by the company in response to this regulatory breach.

Three companies are set to see their share lock-in periods expire on Wednesday, October 15, potentially increasing the supply of tradable shares in the market. This development could impact the trading dynamics of these stocks.

Companies Affected

Key Highlights

Anthem BioSciences

• The stock has shown positive momentum since its July listing, gaining 8.00% from its initial price of ₹570.00 per share.

Shringar House of Mangalsutra

• The company's ₹400.00 crore IPO was oversubscribed by 60 times, indicating strong investor interest.
• Currently, the stock is trading close to its listing price of ₹188.50.

Dev Accelerator

• Despite the upcoming lock-in expiry, the stock has faced challenges since its September listing, declining 21.00% from its IPO price.

Implications of Lock-in Expiry

It's important to note that while the end of lock-in periods makes these shares eligible for trading, it does not guarantee that they will be sold in the open market. Investors should be aware that increased share availability could potentially impact stock prices, but actual market reactions can vary based on multiple factors.

Market participants will be closely watching these stocks for any significant trading activity or price movements following the lock-in expiry.